USGI Medical

USGI Medical is a medical device manufacturer based in San Clemente, California, specializing in endoluminal technologies for incisionless surgery. Founded in 2001, the company aims to improve patient outcomes through minimally invasive endoscopic procedures. With a team of approximately 36 employees, USGI Medical generates around $4 million in revenue and has successfully treated over 16,000 patients worldwide.

The company's mission is to develop technologies that achieve surgical results without incisions, promoting quicker recovery times and reduced healthcare costs. USGI Medical focuses on transitioning invasive laparoscopic procedures to endoscopic treatments, particularly in obesity and gastrointestinal care. Their innovations include the Primary Obesity Surgery Endoluminal (POSE2.0) procedure, which has shown effectiveness in multicenter studies. Recent FDA approvals have allowed the company to expand its research efforts, furthering its commitment to advancing incisionless surgical techniques.